Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study

Abstract Background Acute leukemias are malignant neoplastic diseases that arise from either lymphoid [ALL] or myeloid [AML] cell lines that are distinguished by the proliferation of BM non-functional immature cells and subsequently released into the bloodstream. ALL is prevalent malignancy in young...

Full description

Bibliographic Details
Main Authors: Samir Ali Abd El-Kaream, Samia Abd El-Moneim Ebied, Nadia Ali Sadek, Dina Mohamed Saad, Eman Attia Nadwan
Format: Article
Language:English
Published: SpringerOpen 2021-08-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:https://doi.org/10.1186/s43042-021-00186-5
_version_ 1818907942740557824
author Samir Ali Abd El-Kaream
Samia Abd El-Moneim Ebied
Nadia Ali Sadek
Dina Mohamed Saad
Eman Attia Nadwan
author_facet Samir Ali Abd El-Kaream
Samia Abd El-Moneim Ebied
Nadia Ali Sadek
Dina Mohamed Saad
Eman Attia Nadwan
author_sort Samir Ali Abd El-Kaream
collection DOAJ
description Abstract Background Acute leukemias are malignant neoplastic diseases that arise from either lymphoid [ALL] or myeloid [AML] cell lines that are distinguished by the proliferation of BM non-functional immature cells and subsequently released into the bloodstream. ALL is prevalent malignancy in young, while AML in older. Diagnosis is usually routinely performed through peripheral blood count and smear then confirmed by BM aspirate. It is remarkable to notice that leukemia can be manifested at high, low, and even at normal leucocyte count. While treatment results have improved steadily over the last decades in younger and adults, limited changes have been in survival among subjects of age > 60 years. Aim of the work is to measure the serum estrogen [E2] and its soluble receptor [ER] levels in acute leukemia patients and extrapolate its possible clinical significance. This study included 40 [20 females and 20 males] healthy volunteers clinically free from any disease, 40 [20 females and 20 males] AML patients, and 40 [20 females and 20 males] ALL. To all subjects, serum E2 and its soluble ER level were investigated by ELISA. Results Serum E2 [pg/ml] level was lower in AML and ALL female and male patients groups than control group. Serum ER [ng/ml] level was lower in AML and ALL female and male patients groups than control group. Conclusion Estimation of serum E2 and its soluble ER level is of edifying diagnostic value. Determination of serum E2 and its soluble ER level in AML and ALL patients is of value in deciding treatment therapeutic target protocol.
first_indexed 2024-12-19T22:03:08Z
format Article
id doaj.art-dad1b4ab2b1a468ca2b0466f52e3a22e
institution Directory Open Access Journal
issn 2090-2441
language English
last_indexed 2024-12-19T22:03:08Z
publishDate 2021-08-01
publisher SpringerOpen
record_format Article
series Egyptian Journal of Medical Human Genetics
spelling doaj.art-dad1b4ab2b1a468ca2b0466f52e3a22e2022-12-21T20:04:06ZengSpringerOpenEgyptian Journal of Medical Human Genetics2090-24412021-08-0122111010.1186/s43042-021-00186-5Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control studySamir Ali Abd El-Kaream0Samia Abd El-Moneim Ebied1Nadia Ali Sadek2Dina Mohamed Saad3Eman Attia Nadwan4Department of Applied Medical Chemistry, Medical Research Institute, Alexandria UniversityDepartment of Applied Medical Chemistry, Medical Research Institute, Alexandria UniversityDepartment of Hematology, Medical Research Institute, Alexandria UniversityDepartment of Applied Medical Chemistry, Medical Research Institute, Alexandria UniversityDepartment of Internal Medicine, Hematology Unit, Faculty of Medicine, Alexandria UniversityAbstract Background Acute leukemias are malignant neoplastic diseases that arise from either lymphoid [ALL] or myeloid [AML] cell lines that are distinguished by the proliferation of BM non-functional immature cells and subsequently released into the bloodstream. ALL is prevalent malignancy in young, while AML in older. Diagnosis is usually routinely performed through peripheral blood count and smear then confirmed by BM aspirate. It is remarkable to notice that leukemia can be manifested at high, low, and even at normal leucocyte count. While treatment results have improved steadily over the last decades in younger and adults, limited changes have been in survival among subjects of age > 60 years. Aim of the work is to measure the serum estrogen [E2] and its soluble receptor [ER] levels in acute leukemia patients and extrapolate its possible clinical significance. This study included 40 [20 females and 20 males] healthy volunteers clinically free from any disease, 40 [20 females and 20 males] AML patients, and 40 [20 females and 20 males] ALL. To all subjects, serum E2 and its soluble ER level were investigated by ELISA. Results Serum E2 [pg/ml] level was lower in AML and ALL female and male patients groups than control group. Serum ER [ng/ml] level was lower in AML and ALL female and male patients groups than control group. Conclusion Estimation of serum E2 and its soluble ER level is of edifying diagnostic value. Determination of serum E2 and its soluble ER level in AML and ALL patients is of value in deciding treatment therapeutic target protocol.https://doi.org/10.1186/s43042-021-00186-5EstrogenEstrogen receptorAcute leukemia
spellingShingle Samir Ali Abd El-Kaream
Samia Abd El-Moneim Ebied
Nadia Ali Sadek
Dina Mohamed Saad
Eman Attia Nadwan
Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
Egyptian Journal of Medical Human Genetics
Estrogen
Estrogen receptor
Acute leukemia
title Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
title_full Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
title_fullStr Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
title_full_unstemmed Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
title_short Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study
title_sort serum estrogen and its soluble receptor levels in egyptian patients with acute leukemia case control study
topic Estrogen
Estrogen receptor
Acute leukemia
url https://doi.org/10.1186/s43042-021-00186-5
work_keys_str_mv AT samiraliabdelkaream serumestrogenanditssolublereceptorlevelsinegyptianpatientswithacuteleukemiacasecontrolstudy
AT samiaabdelmoneimebied serumestrogenanditssolublereceptorlevelsinegyptianpatientswithacuteleukemiacasecontrolstudy
AT nadiaalisadek serumestrogenanditssolublereceptorlevelsinegyptianpatientswithacuteleukemiacasecontrolstudy
AT dinamohamedsaad serumestrogenanditssolublereceptorlevelsinegyptianpatientswithacuteleukemiacasecontrolstudy
AT emanattianadwan serumestrogenanditssolublereceptorlevelsinegyptianpatientswithacuteleukemiacasecontrolstudy